C/M CAPITAL PARTNERS, LP - 20 May 2025 SCHEDULE 13G Report for Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share (BDRX)

Filing Manager
C/M CAPITAL PARTNERS, LP
Reporting Manager
Jonathan Juchno
Security
Biodexa Pharmaceuticals Plc Ordinary Shares, nominal value 0.00005 GBP per share
Symbol
BDRX
Shares outstanding
25,770,441,176 shares
Disclosed Ownership
1,752,390,000 shares
Ownership
6.8%
Form type
SCHEDULE 13G
Filing time
28 May 2025, 17:59:16 UTC
Date of event
20 May 2025
Previous filing
18 Feb 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Cavalry Fund I LP 5.7% 1,460,870,000 0 1,460,870,000 /s/ Thomas Walsh By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
C/M Capital Partners, LP 5.7% 1,460,870,000 0 1,460,870,000 /s/ Thomas Walsh Thomas Walsh, Partner
Cavalry Investment Fund LP 0.3% 74,830,000 0 74,830,000 /s/ Thomas Walsh By: Cavalry Fund GP, LLC, General Partner, By: Thomas Walsh, Managing Member
Cavalry Fund I Management LLC 0.3% 74,830,000 0 74,830,000 /s/ Thomas Walsh Thomas Walsh, Manager
Mercer Street Global Opportunity Fund, LLC 1.1% 291,520,000 0 291,520,000 /s/ Jonathan Juchno By: NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
Mercer Street Capital Partners, LLC 1.1% 291,520,000 0 291,520,000 /s/ Jonathan Juchno Jonathan Juchno, Authorized Representative
Thomas Walsh 6% 1,535,700,000 0 1,535,700,000 /s/ Thomas Walsh Thomas Walsh, Individually
Jonathan Juchno 6.8% 1,752,390,000 0 1,752,390,000 /s/ Jonathan Juchno Jonathan Juchno, Individually